Pharmacokinetic (PK) and pharmacodynamic (PD) analysis from a phase I study of PF-03446962, a fully human mab against ALK1, a TGF-beta receptor involved in tumor angiogenesis.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Laura Williams Goff, Hossein Borghaei, Roger B. Cohen, Jordan Berlin, Cristina Noberasco, Corrado Gallo Stampino, Erjian Wang, James Andrew Williams, Patricia A English, Filippo De Braud
Language: English
Topic: TGF-β signaling in diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2597590768